MedPath
HSA Approval

LATANDROPS EYE DROPS SOLUTION 50mcg/ml

SIN14590P

LATANDROPS EYE DROPS SOLUTION 50mcg/ml

LATANDROPS EYE DROPS SOLUTION 50mcg/ml

August 15, 2014

TRANET HOLDINGS PTE LTD

TRANET HOLDINGS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTRANET HOLDINGS PTE LTD
Licence HolderTRANET HOLDINGS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01EE01

latanoprost

Manufacturer Information

TRANET HOLDINGS PTE. LTD.

VIANEX SA

Active Ingredients

Latanoprost

0.050 mg

Latanoprost

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.